- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Caribou Biosciences Inc (CRBU)
Caribou Biosciences Inc stock price live, this page displays NASDAQ CRBU stock exchange data. View the CRBU premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Caribou Biosciences Inc real time stock price chart below.
What Is the Caribou Biosciences Inc Stock Price Today?
The Caribou Biosciences Inc stock price today is 1.730.
What Is the Stock Symbol for Caribou Biosciences Inc?
The stock symbol for Caribou Biosciences Inc is ""CRBU.""
What Stock Exchange Does Caribou Biosciences Inc Trade On?
Caribou Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Caribou Biosciences Inc a Good Stock to Buy?
Determining whether Caribou Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CRBU quote. (ISIN: US1420381089)
What Is the Caribou Biosciences Inc Stock Price Today?
The Caribou Biosciences Inc stock price today is 1.730.
What Is the Stock Symbol for Caribou Biosciences Inc?
The stock symbol for Caribou Biosciences Inc is ""CRBU.""
What Stock Exchange Does Caribou Biosciences Inc Trade On?
Caribou Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Caribou Biosciences Inc a Good Stock to Buy?
Determining whether Caribou Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CRBU quote. (ISIN: US1420381089)
NASDAQ
Currency in USD
1.730
-0.080(-4.42%)
Closed·
After Hours
1.711-0.019(-1.08%)
·
Fair Value
An estimate of a Caribou Biosciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.715
1.870
52 wk Range
0.660
3.000
CRBU Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
CRBU is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Caribou Biosciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.7151.870
52 wk Range
0.6603.000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CRBU Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Caribou Biosciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
9.143
Upside
+428.49%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Caribou Biosciences Inc Company Profile
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally. The company’s lead product candidate include CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma, refractory systemic lupus erythematosus, lupus nephritis, and extrarenal lupus. It also develops CB-011, an anti-BCMA allogeneic CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma; and CB-012, an allogeneic anti-CD371 CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
Caribou Biosciences Inc SWOT Analysis
CRISPR Pioneer's Pivot | Caribou Biosciences stands at a critical juncture, leveraging its proprietary CRISPR technology to develop transformative therapies across multiple disease areas |
Pipeline Progress | Explore Caribou's advancing clinical trials, including multiple myeloma and lupus studies, with key data releases and Phase III initiation on the horizon |
Financial Landscape | Delve into Caribou's financial health, balancing a strong liquidity position against significant R&D investments, with analyst price targets ranging from $14 to $19 |
Market Differentiation | Learn how Caribou's HLA-matching hypothesis and scientific approach could provide a competitive edge in the rapidly evolving gene editing therapeutics market |
Compare CRBU to Peers and Sector
Metrics to compare | CRBU | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCRBUPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.1x | −2.0x | −0.5x | |
PEG Ratio | 0.08 | −0.05 | 0.00 | |
Price/Book | 0.7x | 0.9x | 2.6x | |
Price / LTM Sales | 16.2x | 4.5x | 3.3x | |
Upside (Analyst Target) | 246.8% | 599.4% | 43.4% | |
Fair Value Upside | Unlock | 38.6% | 7.1% | Unlock |
Analyst Ratings
7 Buy
1 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 9.143
(+428.49% Upside)
Earnings
Latest Release
May 08, 2025
EPS / Forecast
-0.43 / -0.45
Revenue / Forecast
2.35M / 1.50M
People Also Watch
FAQ
What Stock Exchange Does Caribou Biosciences Trade On?
Caribou Biosciences is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Caribou Biosciences?
The stock symbol for Caribou Biosciences is "CRBU."
What Is the Caribou Biosciences Market Cap?
As of today, Caribou Biosciences market cap is 160.90M.
What Is Caribou Biosciences's Earnings Per Share (TTM)?
The Caribou Biosciences EPS (TTM) is -1.62.
When Is the Next Caribou Biosciences Earnings Date?
Caribou Biosciences will release its next earnings report on 11 Aug 2025.
From a Technical Analysis Perspective, Is CRBU a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Caribou Biosciences Stock Split?
Caribou Biosciences has split 0 times.
How Many Employees Does Caribou Biosciences Have?
Caribou Biosciences has 147 employees.
What is the current trading status of Caribou Biosciences (CRBU)?
As of 10 Aug 2025, Caribou Biosciences (CRBU) is trading at a price of 1.73, with a previous close of 1.81. The stock has fluctuated within a day range of 1.72 to 1.87, while its 52-week range spans from 0.66 to 3.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.